Welcome to Wellsmont Group website.
The Wellsmont Group is a consulting and educational services business that focuses on human cancer, infectious diseases and precision medicine. Our goal is to help companies and healthcare organizations advance the understanding, application and adoption of precision medicine solutions for cancer and infectious diseases.
The Wellsmont Group provides value-added services that advance the value of personalized and precision medicine in healthcare by helping our clients unlock the potential of personalized and precision medicine.
Our Background
Our knowledge and expertise included IVD diagnostics, molecular diagnostics, genomic expression profiling, and molecular classification of human disease, specifically cancer and infectious diseases.
Furthermore, our broad expertise enables a comprehensive understanding of the intricate complexities of human disease and how this understanding is aligned with laboratory testing, patient assessment, and personalized approach to clinical management.
Our expertise and background enables the Wellsmont group to provide insightful and actionable advice to companies and healthcare organizations as they advance their mission in precision medicine.
Our Consulting Services
We offer strategic consulting and practical advice for companies that have developed a solution to advance improvements in healthcare. Our consulting services include strategy development and review, clinical evidence review and analysis, value proposition assessment, competitive landscape review, publication strategy, and communication efforts. Our consulting activities are designed to enhance the value proposition and competitiveness of new or existing technology solutions within precision medicine.
We offer custom educational programs for organizations and members of the healthcare community to enhance understanding and awareness of advances within precision medicine. Our educational programs include publication efforts, communication plans and presentations at both scientific conferences and webinar-based activities. These educational programs are designed to explain the science and the clinical evidence that underpin the concepts of personalized and precision medicine.
The Wellsmont Group’s unique approach to consulting and educational services is designed to advance the understanding, awareness, and adoption of new solutions in personalized and precision medicine.
Learn more about our Value-Added Services and Consulting Services.
Leant more about our Education and Communication services.
Founder and Executive Director
The Wellsmont Group was founded by Douglas P. Malinowski, Ph.D., who is an experienced healthcare executive with 41 years of experience in the diagnostics industry. His executive leadership has focused on developing innovative products to address unmet needs in human healthcare and create value for the healthcare system and stakeholders.
Dr. Malinowski’s professional career included the development and commercialization of diagnostic products in infectious disease testing, molecular diagnostics, oncology-based screening and detection, oncology-based diagnostic and prognostic assays, molecular pathology, computational pathology, cytology, and histopathology.
Dr. Malinowski is experienced in all phases of strategy development, innovation management, R&D portfolio management, technology development, biomarker research, translational research, assay prototype development, product development and commercialization.
Dr. Malinowski has participated in commercialization pf products and post- launch support of products. These activities included regulatory approval support, clinical evidence surveillance and synthesis, global scientific affairs management, external communication to key stakeholder, clinicians, and global key opinion leader (KOL) engagement.
Read more about Dr. Malinowski here: Who We Are
Dr. Malinowski’s LinkedIn profile can be found here.